Results 1 to 10 of about 22,186 (114)

Steatotic Liver Disease: Metabolic Dysfunction, Alcohol, or Both?

Biomedicines, 2023
Non-alcoholic fatty liver disease (NAFLD) and alcohol-related liver disease (ALD), both of them accounting for fatty liver disease (FLD), are among the most common chronic liver diseases globally, contributing to substantial public health burden.
Katharina Staufer, Rudolf E. Stauber
doaj   +3 more sources

Waiting for the changes after the adoption of steatotic liver disease [PDF]

Clinical and Molecular Hepatology, 2023
Steatotic liver disease was suggested as an overarching term encompassing various etiologies of hepatic steatosis. Experts from multinational liver societies went through the Delphi process, including four rounds of surveys, and consented to adopt a new ...
Eileen L. Yoon, Dae Won Jun
doaj   +1 more source

Necroptosis in ischemia-reperfusion injury of lean and steatotic livers

Liver Research, 2019
Hepatic ischemia-reperfusion (IR) injury is a major complication during liver transplantation, liver resection, and other clinical situations. Increased hepatic IR injury in steatotic livers is a major reason for rejecting the use of steatotic livers for
Hua Sun, Tara McKeen, Hua Wang, Hong-Min Ni   +3 more
doaj   +1 more source

NUPR1 downregulation-mediated impairment of macrophage oxidative phosphorylation participates in the pathogenesis of ulcerative colitis

陆军军医大学学报
Objective Macrophages are key cellular contributors to the development and progression of ulcerative colitis (UC), and their functional state is closely related to oxidative phosphorylation (OXPHOS) capacity. However, changes in macrophage OXPHOS levels
YU Sirui, CHAI Jin
doaj   +1 more source

Targeting the gut microbiota-bile acid axis: Therapeutic strategies for cholestatic liver disease and metabolic dysfunction-associated steatotic liver disease

EngMedicine
Cholestatic liver disease (CSLD) and metabolic dysfunction-associated steatotic liver disease (MASLD) are both associated with abnormal bile acid (BA) metabolism and have a steadily increasing incidence and prevalence worldwide.
Xingtao Zhao, Ruolan Li, Ruiqi Sun, Qiong Pan, Hongyan Lu, Jin Chai   +5 more
doaj   +1 more source

Characteristics of Metabolic Dysfunction-Associated Steatotic Liver Disease and Its Risk for Hepatic Fibrosis in 476,124 Korean Adults: A Cross-Sectional Study [PDF]

Endocrinology and Metabolism
As the new terminology of metabolic dysfunction-associated steatotic liver disease (MASLD) and MASLD with increased alcohol intake (MetALD) has emerged, the clinical significance of MASLD is increasing.
Da Yeon Lee, Ji-Hee Ko, Han-Na Jang, Sun Joon Moon, Hye-Mi Kwon, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Eun-Jung Rhee   +9 more
doaj   +1 more source

Multi-omics technologies in the study of clinical heterogeneity of metabolic associated fatty liver disease

Neike lilun yu shijian
Metabolic associated fatty liver disease (MAFLD) is the most prevalent chronic liver disease worldwide and has become an important public health issue. MAFLD not only impairs liver function but is also closely associated with an increased risk of multi ...
Jingjing DING, Jin CHAI
doaj   +1 more source

Aluminum adjuvant promotes liver inflammation and fibrosis in mice: A novel approach to establish a liver fibrosis animal model

Liver Research
Background and aims: Liver fibrosis is a prevalent pathological stage of various chronic liver diseases and has the potential to progress to liver cirrhosis and hepatocellular carcinoma.
Zhixian Zhu, Sen Liang, Nan Zhao, Huiling Zou, Liangjun Zhang, Xiaoxun Zhang, Jin Chai   +6 more
doaj   +1 more source

Mapping artificial intelligence adoption in hepatology practice and research: challenges and opportunities in MENA region

Frontiers in Medicine
BackgroundArtificial intelligence (AI) is increasingly relevant to hepatology, yet real-world adoption in the Middle East and North Africa (MENA) is uncertain.
Mohamed El-Kassas, Mohamed El-Kassas, Mohamed El-Kassas, Rofida Khalifa, Mohammed A. Medhat, Yusuf Yilmaz, Yusuf Yilmaz, Ali Tumi, Ali Tumi, Asma Labidi, Asma Labidi, Maen Almattooq, Maen Almattooq, Faisal M. Sanai, Faisal M. Sanai, Mohamed Elbadry, Mohamed Elbadry, Mohammed Omer Mohammed, Mohamed Abdelhakim Mahdy, Nermeen Abdeen, Hend Radwan, Walaa Abdelhamed, Majed Almaghrabi, Majed Almaghrabi, Mai Fared, Abdel-Naser Elzouki, Abdel-Naser Elzouki, Khalid A. Alswat, Khalid A. Alswat, Khalid M. AlNaamani, Khalid M. AlNaamani, the Steatotic Liver Disease Study Foundation in Middle East and North Africa (SLMENA) Collaborators, Heba Shafeak Abd El Khalik, Summer Saad Abdalhussain, Yasser Abdelghani, Mohamed Omar Abdelmalek, Aya Milod Abdo, Ali Adil Abdulhussein, Maheeba Abdulla, Aras Aziz Abdulla, Hepatology Subspecialty Program, Harem Sattar Abdulqader, Hossameldin Fathy Abou Elkhier, Ayman Mohammed AbuHelal, Imad Mohammad Abumallouh, Gupse Adali, Abdalaziz Omar Adali, Ahmed Hatim Moahmed Ahmed, Hasnaa Mohammed Ahmed, YASIR Khudhair Ahmed, Mohammed Hussien Ahmed Hussien, Halit Tugrul Akarca, Mehmet Akca, Remzi A. Akdogan, Meral Akdogan Kayhan, Murat Akyildiz, Seyma Handan Akyon, Said Al Alawi, Kawkab Salim Al Balushi, Nooreen Yousuf Al Balushi, Yousuf Said Mahmood Al Balushi, Badriya S Al Farsi, Fat’hiya Mohammed Al Harthy, Al Warith Al Hashmi, Salah Al Jabri, Maimouna N Al Mandhari, Nasser M AL Masri, Jawahar H Al Noumani, Issa Saif Al Qarshoubi, Advanced Endoscopy, Research Centre, Halima Hamed Shuaili, Siham Sinani, Motasam Belah Swayah, Abdulnasser Aladawi, Ali Alali, Abduljaleel Alalwan, AL-Qasim AL-Bahlani, Fatih Albayrak, Mustafa M. Aldaqrum, Ahmed K Al-Darmaki, Hisham Abdullah AlDhahab, Saad Aldosari, Samer Al-Dury, Ahmed Abdurrahman Algeblawi, Abdullah Saeed Alghamdi, Mohammed Y Alghamdi, Nadya Abdullah AlHarthy, Omar A Alhusayni, Randa S Ali, Wesam Saif Ali, Mohammed Aljawad, Abdullah Humaid Alkalbani, Nawal Mehdi Alkhalidi, Fahd Almalki, Mohammad Jameel Almatrafi, Zakariya AL-Naamani, Faisal Mania Alotaibi, Hassan Abdullah Alqartoobi, Farooq Fouad Alrawi, Salim Mohammed Alriyami, Abdulmalik M Alsabban, Marwan T A Alsari, Mohamed A Alsenbesy, Omar Alsiyabi, Abdulatif Alsuleimani, Jamal Abdulnasser Altamimi, Loai A Altayib, Adnan Alzanbagi, Derya Arı, İpek Bilge Aslan, Ahmed Mohamed Assar, Mohamed L. Asser, Halil Atasoy, Dina Attia, Endemic Medicine, Gokhan Aydin, Rifat Furkan Aydın, Mohammed Diaaldin Ayoub, Soran Baban, Yasemin Hatice Balaban, Metin Basaranoglu, Dalia Basulayman, Reem Abdulhay Ben Omran, Camélia Berhili, Ruchir Kumar Bichu, Mehmet Biricik, Ali Rıza Çalışkan, Rasim E. Cankurtaran, Deha Duran Cetin, Sedat Çiçek, Hatice Colak, Arif Mansur Cosar, Nabil Debzi, Hakan Demiröz, Berkay Dertsiz, Elham Salah Desokey, Hakan Dursun, Maissa E El Raziky, Reda Mohamed Elbadawy, Nada El-Domiaty, Asem Elfert, Ahmed Belgasem Elhaddad, Ahmed F Elhassi, Hanaa Mostafa El-Karaksy, Mumajed Lutfi Elmsellati, Mohamed Hassan Elnadry, Infectious Diseases, Fatma Elrashdy, Medhat Elsahhar, Mortada H. F. El-Shabrawi, Eman E. Elshemy, Iman Elsherif, Doaa Elwazzan, Ghada Younes Elzewiei, Ilkay Ergenç, Murat Erkut, Hasan Eruzun, Mohammed Ezz-Eldin, Mohanad Faisal, Eman M. Fares, Sami Fidan, Mahrez Fissah, Mostafa Taha Gabr, Ghada M Galal, Saleh A. Garad, Prof A. A. Gehani, Ahmed Gouda, Donia Gouiaa, Gamze Gül, Murat Taner Gülşen, Burcu Gurbuz, Khaled Mohd Hamad, Aya Hammami, Mustafa Harı, Zekiye Nur Harput, Dalia Hassan, Norhan Ali Hassan, Marwa Khalaf Hassan, Gdoura Hela, Amal A Helmy, Sayed Mohamed Hemdan, Abdullah İlhan, Mona Ismail, Kemal Yunus İyiyapıcı, Amar Jasem, Bola Rajendra Kamath, Saibe Merve Kazdal, Caglayan Keklikkiran, Emre Batuhan Kenger, Onur Keskin, Yusuf Bünyamin Ketenci, Nahla Ahmed Khalaf, Mohammed Adnan Khan, Fatih Kıvrakoğlu, Ayşenur Kördüğüm, Hüseyin Köseoğlu, Norhan Osama Mady, Reem Ezzat Mahdy, Nahed A Makhlouf, Khaled Matar, Rasha Matar, Advanced Endoscopy, Research Centre, Mohammad Mawardi, Sahide N. I. Melez, Aymen Nassem Menessy, Gastroenterology Unit, Bilge Meral Koç, Adnan Misellati, Taha Ahmad Mohamad, Hepatology Subspecialty Program, Abrar Mohamed, Omed Oubed Mohammad, Malavan H. Mohammed, Khairy Hammam Morsy, Hussein M Mossa, Ehab F Moustafa, Benazzouz Mustapha, Hanaa Mahmoud Nagdy, Youssef Eshak Naguib, Husna Omran, Youssef Hadi Osman, Murat Ozdede, Tugce Ozlu Karahan, Bengi Öztürk, Yavuz E Parlar, Yunus Halil Polat, Almotasembillah Rammal, Dr. Asia Salah Rasool, Hepatology Subspecialty Program, Mehmet Ali Şahan, Yara Mohamed Salah, Nairoz Alnuri Sasi, Serhat Saylam, Ebubekir Şenateş, Hande Seven Avuk, Mohammed Raziuddin Shajee, Mona Helmy Shehata, Hend I Shousha, İbrahim Halil Söylemez, Cemal Firat Subasi, Marlain Odeh Swaiss, Said Taharboucht, Mostafa Tharwat, Melike Tuncer, Ilker Turan, Dilara Turan Gökçe, Gaye Ulgut, Yilmaz Usluoglu, Muge Ustaoglu, Imam Waked, Marwa Y, Haythem Yacoub, Alper Yurci, Moshera Ahmed Zaki, Ysear Zakri   +256 more
doaj   +1 more source

Small Steatotic HCC: A Radiological Variant Associated With Improved Outcome After Ablation

Hepatology Communications, 2021
Percutaneous thermal ablation is a validated treatment option for small hepatocellular carcinoma (HCC). Steatotic HCC can be reliably detected by magnetic resonance imaging.
Margaux Hermida, Ancelin Preel, Eric Assenat, Lauranne Piron, Christophe Cassinotto, José Ursic‐Bedoya, Chloé Guillot, Astrid Herrero, Fabrizio Panaro, Georges‐Philippe Pageaux, Boris Guiu   +10 more
doaj   +1 more source